Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
and FGFR3 with IC50=~1 nM
33H2/b20-10+
R59022 (10 μM) potentiates aggregation
Solubility: DMSO: 47 mg/mL(198
Pardoprunox acts as a partial agonist in the induction of [(35)S]GTPgammaS binding (intrinsic activity of 67%
A-966492 Size:2mg solid and FGFR3 with IC50=~1 nMA 966492 is a potent PARP inhibitor, which displayed excellent potency against the PARP 1 enzyme with a K(i) of 1 nM and an EC(50) of 1 nM in a whole cell assay. In addition, A 966492 is orally bioavailable across multiple species, crosses the blood brain barrier, and appears to distribute into tumor tissue. It also demonstrated good in vivo efficacy in a B16F10 subcutaneous murine melanoma model in combination with temozolomide and in an MX 1 breast